- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MRK
Recent news which mentions MRK
This Sentiment Gauge Just Reached Its Most Optimistic Level Since Pre-Covid Days. Time to Buy Stocks?
June 29, 2023
From Motley Fool
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
June 28, 2023
From MarketWatch
Terns Pharmaceuticals Is "Attractively Priced" Despite Pressure From Eli Lilly's Obesity Data, Analyst Says
June 28, 2023
From Benzinga
From Benzinga
Merck & Co Accused of Underplaying Mental Health Risks from Asthma and Allergy Drug Singulair
June 26, 2023
Tickers
MRK
From Benzinga
2 Low-Priced Stocks That Could Make You Richer
June 26, 2023
From Motley Fool
From Motley Fool
Dear SCHD ETF Fans, Mark Your Calendars for June 26
June 22, 2023
From InvestorPlace
Pharmaceutical Lobbying Group Challenges Biden Administration Over Medicare Price Negotiations
June 22, 2023
From Benzinga
Merck Says Keytruda Regimen Fails To Improve Event-Free Survival In Gastric Cancer Patients
June 20, 2023
Tickers
MRK
From Benzinga
Is Merck Stock a Top Buy Right Now?
June 19, 2023
From Motley Fool
From Motley Fool
Merck's Keytruda Combo Therapy Hits Primary Goal In Patients With Rare Form Of Gastric Cancer
June 16, 2023
Tickers
MRK
From Benzinga
From Benzinga
Why Are IO Biotech Shares Trading Lower Today
June 14, 2023
From Benzinga
2 Healthcare Stocks That Could Make You Richer
June 14, 2023
From Motley Fool
Eli Lilly CEO Joins Other Pharma Execs, Raises Concern Over Medicare Price Negotiations Impacting Drug Development
June 14, 2023
From Benzinga
Negotiation or Coercion? Big Pharma and US Chamber of Commerce Tackle Government on Drug Prices
June 12, 2023
From Benzinga
From Motley Fool
From Motley Fool
From Motley Fool
The 3 Best Defensive Stocks to Buy in June 2023
June 07, 2023
From InvestorPlace
Merck lawsuit challenging Medicare drug price negotiation signals long battle ahead, experts say
June 06, 2023
From MarketWatch
Pharmaceutical Giant Merck Challenges Inflation Reduction Act over Medicare Drug Pricing, Calls It 'Extortion'
June 06, 2023
From Benzinga
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts
June 06, 2023
From Benzinga
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.